BICO Group AB (publ) (BICO.ST)
SEK 34.84
(5.07%)
SEK 34.84
(5.07%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -12.99 SEK | -224.75% |
| 2021 | -4.00 SEK | -172.11% |
| 2020 | -1.47 SEK | -8955.42% |
| 2019 | 0.02 SEK | -56.66% |
| 2018 | 0.04 SEK | 239.27% |
| 2017 | -0.03 SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q2 | -12.73 SEK | -657.74% |
| 2023 Q3 | -1.00 SEK | 92.14% |
| 2023 Q1 | -1.68 SEK | 88.06% |
| 2022 Q3 | 1.04 SEK | 52.94% |
| 2022 Q2 | 0.68 SEK | 200.0% |
| 2022 Q1 | -0.68 SEK | -70.0% |
| 2022 FY | - SEK | -224.75% |
| 2022 Q4 | -14.07 SEK | -1452.88% |
| 2021 FY | - SEK | -172.11% |
| 2021 Q2 | -0.89 SEK | 1.11% |
| 2021 Q3 | -1.81 SEK | -103.37% |
| 2021 Q4 | -0.40 SEK | 77.9% |
| 2021 Q1 | -0.90 SEK | 0.0% |
| 2020 Q1 | -0.43 SEK | -230.77% |
| 2020 FY | - SEK | -8955.42% |
| 2020 Q2 | -0.58 SEK | -34.88% |
| 2020 Q3 | -0.32 SEK | 44.83% |
| 2019 Q1 | 0.04 SEK | 100.0% |
| 2019 FY | - SEK | -56.66% |
| 2019 Q2 | 0.01 SEK | -79.25% |
| 2019 Q4 | -0.13 SEK | -177.19% |
| 2019 Q3 | -0.05 SEK | -665.06% |
| 2018 Q4 | 0.02 SEK | -42.86% |
| 2018 FY | - SEK | 239.27% |
| 2018 Q1 | 0.00 SEK | 116.22% |
| 2018 Q2 | 0.01 SEK | 566.67% |
| 2018 Q3 | 0.04 SEK | 191.67% |
| 2017 Q2 | -0.02 SEK | -1125.0% |
| 2017 FY | - SEK | 0.0% |
| 2017 Q1 | 0.00 SEK | -73.33% |
| 2017 Q4 | -0.01 SEK | -265.67% |
| 2017 Q3 | 0.01 SEK | 132.68% |
| 2016 Q4 | 0.01 SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Acarix AB (publ) | -0.16 SEK | -8018.75% |
| ADDvise Group AB (publ) | 0.56 SEK | 2419.643% |
| ADDvise Group AB (publ) | 0.56 SEK | 2419.643% |
| Arcoma AB | 0.19 SEK | 6936.842% |
| Bactiguard Holding AB (publ) | -3.95 SEK | -228.861% |
| Boule Diagnostics AB (publ) | 0.64 SEK | 2129.688% |
| CellaVision AB (publ) | 5.46 SEK | 337.912% |
| Clinical Laserthermia Systems AB (publ) | -23.76 SEK | 45.328% |
| Chordate Medical Holding AB (publ) | -0.13 SEK | -9892.308% |
| C-Rad AB (publ) | 1.05 SEK | 1337.143% |
| Duearity AB (publ) | -0.40 SEK | -3147.5% |
| Dignitana AB (publ) | -0.25 SEK | -5096.0% |
| Episurf Medical AB (publ) | -0.36 SEK | -3508.333% |
| Getinge AB (publ) | 8.86 SEK | 246.614% |
| Scandinavian Real Heart AB (Publ) | -0.70 SEK | -1755.714% |
| Iconovo AB (publ) | -4.39 SEK | -195.9% |
| Integrum AB (publ) | 0.23 SEK | 5747.826% |
| Luxbright AB (publ) | -0.37 SEK | -3410.811% |
| Mentice AB (publ) | -0.11 SEK | -11709.091% |
| OssDsign AB (publ) | -1.59 SEK | -716.981% |
| Paxman AB (publ) | 0.44 SEK | 3052.273% |
| Promimic AB (publ) | -0.50 SEK | -2498.0% |
| Qlife Holding AB (publ) | -526.52 SEK | 97.533% |
| SciBase Holding AB (publ) | -0.51 SEK | -2447.059% |
| ScandiDos AB (publ) | -0.32 SEK | -3959.375% |
| Sectra AB (publ) | 2.22 SEK | 685.135% |
| Sedana Medical AB (publ) | -0.60 SEK | -2065.0% |
| Senzime AB (publ) | -1.45 SEK | -795.862% |
| SpectraCure AB (publ) | -0.21 SEK | -6085.714% |
| Stille AB | 5.31 SEK | 344.633% |
| Vitrolife AB (publ) | -28.44 SEK | 54.325% |
| Xvivo Perfusion AB (publ) | 3.07 SEK | 523.127% |